Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illinois Tool Works
ITW
|
+$224M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$199M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$129M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$116M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$1.15B |
| 3 |
NVIDIA
NVDA
|
+$628M |
| 4 |
Amazon
AMZN
|
+$524M |
| 5 |
Tesla
TSLA
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Financials | 11.58% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $213K | ﹤0.01% |
1,384
-18
| -1% | -$2.75K |
|
3877
Lantronix
LTRX
$240M
| $212K | ﹤0.01% |
59,496
| – | – |
|
|
VNET
3878
VNET Group
VNET
$2.04B
| $211K | ﹤0.01% |
136,329
+53,046
| +64% | +$97.9K |
|
3879
BlackRock Resources & Commodities Strategy Trust
BCX
$919M
| $211K | ﹤0.01% |
23,268
+140
| +0.6% | +$1.21K |
|
3880
Champions Oncology
CSBR
$74.5M
| $209K | ﹤0.01% |
42,689
-2,228
| -5% | -$13K |
|
3881
Cellectar Biosciences
CLRB
$20.5M
| $208K | ﹤0.01% |
1,745
+1,322
| +313% | +$143K |
|
3882
VirTra
VTSI
$34.9M
| $208K | ﹤0.01% |
20,201
-17
| -0.1% | -$182 |
|
|
RA
3883
Brookfield Real Assets Income Fund
RA
$708M
| $206K | ﹤0.01% |
+15,980
| New | +$207K |
|
3884
Urban One Class D
UONEK
$22.8M
| $206K | ﹤0.01% |
10,117
-547
| -5% | -$16.7K |
|
3885
Quest Resource Holding
QRHC
$26.8M
| $206K | ﹤0.01% |
24,039
+109
| +0.5% | +$776 |
|
3886
LifeVantage
LFVN
$81.1M
| $206K | ﹤0.01% |
34,070
-2,210
| -6% | -$14K |
|
3887
Santander
BSBR
$42.5B
| $204K | ﹤0.01% |
35,742
-5,006
| -12% | -$29.4K |
|
|
LL
3888
DELISTED
LL Flooring Holdings, Inc.
LL
| $204K | ﹤0.01% |
111,716
-4,728
| -4% | -$11.4K |
|
|
CLSD
3889
DELISTED
Clearside Biomedical
CLSD
| $204K | ﹤0.01% |
8,902
+2,784
| +46% | +$60K |
|
|
BRFS
3890
DELISTED
BRF SA
BRFS
| $203K | ﹤0.01% |
62,315
+997
| +2% | +$2.94K |
|
3891
Danaos Corp
DAC
$2.58B
| $203K | ﹤0.01% |
2,810
-364
| -11% | -$26.8K |
|
3892
Citizens
CIA
$239M
| $202K | ﹤0.01% |
94,602
-559
| -0.6% | -$1.46K |
|
3893
Enel Chile
ENIC
$6.14B
| $201K | ﹤0.01% |
65,856
-7,523
| -10% | -$22.1K |
|
3894
TIM SA
TIMB
$9.16B
| $199K | ﹤0.01% |
11,229
-3,615
| -24% | -$65.6K |
|
|
SYRS
3895
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $197K | ﹤0.01% |
36,897
-3,073
| -8% | -$21.2K |
|
3896
Genius Sports
GENI
$1.85B
| $197K | ﹤0.01% |
34,512
-4,452
| -11% | -$28.6K |
|
3897
Spero Therapeutics
SPRO
$67.7M
| $197K | ﹤0.01% |
114,559
+25,678
| +29% | +$40.3K |
|
3898
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.29B
| $197K | ﹤0.01% |
14,743
+89
| +0.6% | +$1.13K |
|
|
FNCB
3899
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $196K | ﹤0.01% |
32,260
-32
| -0.1% | -$199 |
|
3900
Anixa Biosciences
ANIX
$116M
| $196K | ﹤0.01% |
62,662
+11,165
| +22% | +$44.5K |
|
Similar funds
Northern Trust's Q1 2024 Portfolio in Review
As of Q1 2024, Northern Trust held 4,565 positions worth $579B, up 4.8% from $552B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Northern Trust withdrew a net $22.5B in Q1 2024, closing 140 positions and reducing 3,160 holdings. Its most notable exit was Splunk Inc, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Northern Trust opened a new position in Arcadium Lithium plc worth $50.1M.
- Northern Trust's largest Q1 2024 buy was Arcadium Lithium plc: 11,618,079 shares worth $50.1M.
- Northern Trust added most to Illinois Tool Works in Q1 2024, an estimated $224M increase.
- Northern Trust's biggest Q1 2024 reduction was Apple, cutting an estimated $1.44B.
- Northern Trust fully exited Splunk Inc in Q1 2024, selling an estimated $163M.
- Northern Trust's ten largest holdings make up 25% of its $579B portfolio in Q1 2024.
- Northern Trust opened 95 new positions and closed 140 in Q1 2024.
- Northern Trust's portfolio value rose 4.8% quarter-over-quarter to $579B.
Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.